The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients

NCT02134899 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease

Interventions

DRUG: Everolimus
DRUG: Calcineurin inhibitors maintenance

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]